APO Research
Talk to an analyst

APO RESEARCH · REPORT

AAV Gene Therapy Injection

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global AAV Gene Therapy Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025199 pages

Choose your research edition.

Industry ResearchAAV Gene Therapy Injection Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal AAV Gene Therapy Injection Industry Growth and Trends Forecast to 2032103 pages · $3,450 USDMarket StructureGlobal AAV Gene Therapy Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032199 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal AAV Gene Therapy Injection Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal AAV Gene Therapy Injection Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global AAV Gene Therapy Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for AAV Gene Therapy Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for AAV Gene Therapy Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for AAV Gene Therapy Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for AAV Gene Therapy Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of AAV Gene Therapy Injection include Avexis/Novartis (Zolgensma), BioMarin (Roctavian), CSL/uniQure (Hemgenix&Glybera), PTC Therapeutics (Upstaza), Sarepta Therapeutics (Elevidys), Spark/Roche (Luxturna), Pfizer, Suzhou NoJieBeig (Pipeline) and Belief BioMed (Pipeline), among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global AAV Gene Therapy Injection market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of AAV Gene Therapy Injection and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents AAV Gene Therapy Injection revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the AAV Gene Therapy Injection market size, projected growth trends, production technologies, key applications, and end-use industries.

AAV Gene Therapy Injection Segment by Company

Avexis/Novartis (Zolgensma)

BioMarin (Roctavian)

CSL/uniQure (Hemgenix&Glybera)

PTC Therapeutics (Upstaza)

Sarepta Therapeutics (Elevidys)

Spark/Roche (Luxturna)

Pfizer

Suzhou NoJieBeig (Pipeline)

Belief BioMed (Pipeline)

Beijing Innovikang (Pipeline)

AAV Gene Therapy Injection Segment by Type

scAAV9 Vector

AVV5 Vector

AVV2 Vector

AAVrh74 Vector

AAV Gene Therapy Injection Segment by Application

Ophthalmic Diseases

Hemophilia

Spinal Muscular Atrophy (SMA)

Duchenne Muscular Dystrophy (DMD)

Others

AAV Gene Therapy Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global AAV Gene Therapy Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of AAV Gene Therapy Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of AAV Gene Therapy Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of AAV Gene Therapy Injection in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global AAV Gene Therapy Injection industry.

Chapter 3: Detailed analysis of AAV Gene Therapy Injection companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, AAV Gene Therapy Injectionrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global AAV Gene Therapy Injection Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of scAAV9 Vector Table 3. Key Players of AVV5 Vector Table 4. Key Players of AVV2 Vector Table 3. Key Players of AAVrh74 Vector Table 4. Global AAV Gene Therapy Injection Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Ophthalmic Diseases Table 6. Key Players of Hemophilia Table 7. Key Players of Spinal Muscular Atrophy (SMA) Table 8. Key Players of Duchenne Muscular Dystrophy (DMD) Table 9. Key Players of Others Table 10. Global AAV Gene Therapy Injection Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 11. Global AAV Gene Therapy Injection Market Size by Region (2021-2026) & (US$ Million) Table 12. Global AAV Gene Therapy Injection Market Share by Region (2021-2026) Table 13. Global AAV Gene Therapy Injection Market Size by Region (2027-2032) & (US$ Million) Table 14. Global AAV Gene Therapy Injection Market Share by Region (2027-2032) Table 15. AAV Gene Therapy Injection Industry Trends Table 16. AAV Gene Therapy Injection Industry Drivers Table 17. AAV Gene Therapy Injection Industry Opportunities and Challenges Table 18. AAV Gene Therapy Injection Industry Restraints Table 19. Global AAV Gene Therapy Injection Revenue by Company (US$ Million) & (2021-2026) Table 20. Global AAV Gene Therapy Injection Revenue Market Share by Company (2021-2026) Table 21. Global AAV Gene Therapy Injection Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 22. Global AAV Gene Therapy Injection Key Company Head Office and Area Served Table 23. Global AAV Gene Therapy Injection Company, Product Type & Application Table 24. Global AAV Gene Therapy Injection Company Establishment Date Table 25. Global Company Market Concentration Ratio (CR5 and HHI) Table 26. Global AAV Gene Therapy Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 27. Global AAV Gene Therapy Injection Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global AAV Gene Therapy Injection Market Size by Type (2021-2026) & (US$ Million) Table 29. Global AAV Gene Therapy Injection Market Size by Type (2027-2032) & (US$ Million) Table 30. Global AAV Gene Therapy Injection Revenue Market Share by Type (2021-2026) Table 31. Global AAV Gene Therapy Injection Revenue Market Share by Type (2027-2032) Table 32. Global AAV Gene Therapy Injection Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global AAV Gene Therapy Injection Market Size by Application (2021-2026) & (US$ Million) Table 34. Global AAV Gene Therapy Injection Market Size by Application (2027-2032) & (US$ Million) Table 35. Global AAV Gene Therapy Injection Revenue Market Share by Application (2021-2026) Table 36. Global AAV Gene Therapy Injection Revenue Market Share by Application (2027-2032) Table 37. Avexis/Novartis (Zolgensma) Company Information Table 38. Avexis/Novartis (Zolgensma) Business Overview Table 39. Avexis/Novartis (Zolgensma) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. Avexis/Novartis (Zolgensma) AAV Gene Therapy Injection Product Portfolio Table 41. Avexis/Novartis (Zolgensma) Recent Development Table 42. BioMarin (Roctavian) Company Information Table 43. BioMarin (Roctavian) Business Overview Table 44. BioMarin (Roctavian) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. BioMarin (Roctavian) AAV Gene Therapy Injection Product Portfolio Table 46. BioMarin (Roctavian) Recent Development Table 47. CSL/uniQure (Hemgenix&Glybera) Company Information Table 48. CSL/uniQure (Hemgenix&Glybera) Business Overview Table 49. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Injection Product Portfolio Table 51. CSL/uniQure (Hemgenix&Glybera) Recent Development Table 52. PTC Therapeutics (Upstaza) Company Information Table 53. PTC Therapeutics (Upstaza) Business Overview Table 54. PTC Therapeutics (Upstaza) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. PTC Therapeutics (Upstaza) AAV Gene Therapy Injection Product Portfolio Table 56. PTC Therapeutics (Upstaza) Recent Development Table 57. Sarepta Therapeutics (Elevidys) Company Information Table 58. Sarepta Therapeutics (Elevidys) Business Overview Table 59. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. Sarepta Therapeutics (Elevidys) AAV Gene Therapy Injection Product Portfolio Table 61. Sarepta Therapeutics (Elevidys) Recent Development Table 62. Spark/Roche (Luxturna) Company Information Table 63. Spark/Roche (Luxturna) Business Overview Table 64. Spark/Roche (Luxturna) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Spark/Roche (Luxturna) AAV Gene Therapy Injection Product Portfolio Table 66. Spark/Roche (Luxturna) Recent Development Table 67. Pfizer Company Information Table 68. Pfizer Business Overview Table 69. Pfizer AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Pfizer AAV Gene Therapy Injection Product Portfolio Table 71. Pfizer Recent Development Table 72. Suzhou NoJieBeig (Pipeline) Company Information Table 73. Suzhou NoJieBeig (Pipeline) Business Overview Table 74. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Injection Product Portfolio Table 76. Suzhou NoJieBeig (Pipeline) Recent Development Table 77. Belief BioMed (Pipeline) Company Information Table 78. Belief BioMed (Pipeline) Business Overview Table 79. Belief BioMed (Pipeline) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Belief BioMed (Pipeline) AAV Gene Therapy Injection Product Portfolio Table 81. Belief BioMed (Pipeline) Recent Development Table 82. Beijing Innovikang (Pipeline) Company Information Table 83. Beijing Innovikang (Pipeline) Business Overview Table 84. Beijing Innovikang (Pipeline) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Beijing Innovikang (Pipeline) AAV Gene Therapy Injection Product Portfolio Table 86. Beijing Innovikang (Pipeline) Recent Development Table 87. North America AAV Gene Therapy Injection Market Size by Type (2021-2026) & (US$ Million) Table 88. North America AAV Gene Therapy Injection Market Size by Type (2027-2032) & (US$ Million) Table 89. North America AAV Gene Therapy Injection Market Size by Application (2021-2026) & (US$ Million) Table 90. North America AAV Gene Therapy Injection Market Size by Application (2027-2032) & (US$ Million) Table 91. North America AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 92. North America AAV Gene Therapy Injection Market Size by Country (2021-2026) Table 93. North America AAV Gene Therapy Injection Market Size by Country (2027-2032) Table 94. Europe AAV Gene Therapy Injection Market Size by Type (2021-2026) & (US$ Million) Table 95. Europe AAV Gene Therapy Injection Market Size by Type (2027-2032) & (US$ Million) Table 96. Europe AAV Gene Therapy Injection Market Size by Application (2021-2026) & (US$ Million) Table 97. Europe AAV Gene Therapy Injection Market Size by Application (2027-2032) & (US$ Million) Table 98. Europe AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe AAV Gene Therapy Injection Market Size by Country (2021-2026) Table 100. Europe AAV Gene Therapy Injection Market Size by Country (2027-2032) Table 101. China AAV Gene Therapy Injection Market Size by Type (2021-2026) & (US$ Million) Table 102. China AAV Gene Therapy Injection Market Size by Type (2027-2032) & (US$ Million) Table 103. China AAV Gene Therapy Injection Market Size by Application (2021-2026) & (US$ Million) Table 104. China AAV Gene Therapy Injection Market Size by Application (2027-2032) & (US$ Million) Table 105. Asia AAV Gene Therapy Injection Market Size by Type (2021-2026) & (US$ Million) Table 106. Asia AAV Gene Therapy Injection Market Size by Type (2027-2032) & (US$ Million) Table 107. Asia AAV Gene Therapy Injection Market Size by Application (2021-2026) & (US$ Million) Table 108. Asia AAV Gene Therapy Injection Market Size by Application (2027-2032) & (US$ Million) Table 109. Asia AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 110. Asia AAV Gene Therapy Injection Market Size by Country (2021-2026) Table 111. Asia AAV Gene Therapy Injection Market Size by Country (2027-2032) Table 112. South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Type (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Type (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Application (2021-2026) & (US$ Million) Table 115. South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Application (2027-2032) & (US$ Million) Table 116. South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 117. South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2021-2026) Table 118. South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2027-2032) Table 119. Research Programs/Design for This Report Table 120. Authors List of This Report Table 121. Secondary Sources Table 122. Primary Sources List of Figures Figure 1. AAV Gene Therapy Injection Product Image Figure 2. Global AAV Gene Therapy Injection Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global AAV Gene Therapy Injection Market Share by Type: 2025 VS 2032 Figure 4. scAAV9 Vector Image Figure 5. AVV5 Vector Image Figure 6. AVV2 Vector Image Figure 7. AAVrh74 Vector Image Figure 8. Global AAV Gene Therapy Injection Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global AAV Gene Therapy Injection Market Share by Application: 2025 VS 2032 Figure 10. Ophthalmic Diseases Image Figure 11. Hemophilia Image Figure 12. Spinal Muscular Atrophy (SMA) Image Figure 13. Duchenne Muscular Dystrophy (DMD) Image Figure 14. Others Image Figure 15. Global AAV Gene Therapy Injection Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 17. Global AAV Gene Therapy Injection Market Share by Region: 2025 VS 2032 Figure 18. Years Considered Figure 19. Global AAV Gene Therapy Injection Market Share by Players in 2025 Figure 20. Global Top 5 and 10 AAV Gene Therapy Injection Players Market Share by Revenue in 2025 Figure 21. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 22. Global AAV Gene Therapy Injection Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global AAV Gene Therapy Injection Revenue Market Share by Type (2021-2032) Figure 24. Global AAV Gene Therapy Injection Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global AAV Gene Therapy Injection Revenue Market Share by Application (2021-2032) Figure 26. North America AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 27. North America AAV Gene Therapy Injection Market Share by Type (2021-2032) Figure 28. North America AAV Gene Therapy Injection Market Share by Application (2021-2032) Figure 29. North America AAV Gene Therapy Injection Market Share by Country (2021-2032) Figure 30. United States AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 31. Canada AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 32. Mexico AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 33. Europe AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 34. Europe AAV Gene Therapy Injection Market Share by Type (2021-2032) Figure 35. Europe AAV Gene Therapy Injection Market Share by Application (2021-2032) Figure 36. Europe AAV Gene Therapy Injection Market Share by Country (2021-2032) Figure 37. Germany AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 38. France AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 39. U.K. AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 40. Italy AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 41. Russia AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 42. Nordic Countries AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 43. China AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 44. China AAV Gene Therapy Injection Market Share by Type (2021-2032) Figure 45. China AAV Gene Therapy Injection Market Share by Application (2021-2032) Figure 46. Asia AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 47. Asia AAV Gene Therapy Injection Market Share by Type (2021-2032) Figure 48. Asia AAV Gene Therapy Injection Market Share by Application (2021-2032) Figure 49. Asia AAV Gene Therapy Injection Market Share by Country (2021-2032) Figure 50. Japan AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 51. South Korea AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 52. Taiwan AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 53. Southeast Asia AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 54. India AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 55. Australia AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 56. South America, Middle East & Africa AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 57. South America, Middle East & Africa AAV Gene Therapy Injection Market Share by Type (2021-2032) Figure 58. South America, Middle East & Africa AAV Gene Therapy Injection Market Share by Application (2021-2032) Figure 59. South America, Middle East & Africa AAV Gene Therapy Injection Market Share by Country (2021-2032) Figure 60. Brazil AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 61. South Africa AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 62. Saudi Arabia AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 63. Turkey AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 64. Argentina AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 65. UAE AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 66. Egypt AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 67. Chile AAV Gene Therapy Injection Market Size (2021-2032) & (US$ Million) Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • scAAV9 Vector
  • AVV5 Vector
  • AVV2 Vector
  • AAVrh74 Vector
Applications
  • Ophthalmic Diseases
  • Hemophilia
  • Spinal Muscular Atrophy (SMA)
  • Duchenne Muscular Dystrophy (DMD)
  • Others
Companies covered
  • Avexis/Novartis (Zolgensma)
  • BioMarin (Roctavian)
  • CSL/uniQure (Hemgenix&Glybera)
  • PTC Therapeutics (Upstaza)
  • Sarepta Therapeutics (Elevidys)
  • Spark/Roche (Luxturna)
  • Pfizer
  • Suzhou NoJieBeig (Pipeline)
  • Belief BioMed (Pipeline)
  • Beijing Innovikang (Pipeline)

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global AAV Gene Therapy Injection Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 scAAV9 Vector
  5. 1.2.3 AVV5 Vector
  6. 1.2.4 AVV2 Vector
  7. 1.2.5 AAVrh74 Vector
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global AAV Gene Therapy Injection Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Ophthalmic Diseases
  11. 1.3.3 Hemophilia
  12. 1.3.4 Spinal Muscular Atrophy (SMA)
  13. 1.3.5 Duchenne Muscular Dystrophy (DMD)
  14. 1.3.6 Others
  15. 1.4 Global Market Growth Prospects
  16. 1.5 Global AAV Gene Therapy Injection Growth Trends by Region
  17. 1.5.1 Global AAV Gene Therapy Injection Market Size by Region: 2021 VS 2025 VS 2032
  18. 1.5.2 AAV Gene Therapy Injection Market Size by Region (2021-2026)
  19. 1.5.3 AAV Gene Therapy Injection Market Size by Region (2027-2032)
  20. 1.6 Assumptions and Limitations
  21. 1.7 Study Goals and Objectives
  22. 1.8 Years Considered
2 Global AAV Gene Therapy Injection Market Dynamics
  1. 2.1 AAV Gene Therapy Injection Industry Trends
  2. 2.2 AAV Gene Therapy Injection Industry Drivers
  3. 2.3 AAV Gene Therapy Injection Industry Opportunities and Challenges
  4. 2.4 AAV Gene Therapy Injection Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global AAV Gene Therapy Injection Revenue by Company (2021-2026)
  2. 3.2 Global AAV Gene Therapy Injection Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global AAV Gene Therapy Injection Key Company Head office and Area Served
  4. 3.4 Global AAV Gene Therapy Injection Company, Product Type & Application
  5. 3.5 Global AAV Gene Therapy Injection Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global AAV Gene Therapy Injection Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 AAV Gene Therapy Injection Players Market Share by Revenue in 2025
  9. 3.6.3 2025 AAV Gene Therapy Injection Tier 1, Tier 2, and Tier 3
4 AAV Gene Therapy Injection Market by Type
  1. 4.1 Global AAV Gene Therapy Injection Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global AAV Gene Therapy Injection Market Size by Type (2021-2032)
  3. 4.3 Global AAV Gene Therapy Injection Market Size Share by Type (2021-2032)
5 AAV Gene Therapy Injection Market by Application
  1. 5.1 Global AAV Gene Therapy Injection Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global AAV Gene Therapy Injection Market Size by Application (2021-2032)
  3. 5.3 Global AAV Gene Therapy Injection Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Avexis/Novartis (Zolgensma)
  2. 6.1.1 Avexis/Novartis (Zolgensma) Company Information
  3. 6.1.2 Avexis/Novartis (Zolgensma) Business Overview
  4. 6.1.3 Avexis/Novartis (Zolgensma) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Avexis/Novartis (Zolgensma) AAV Gene Therapy Injection Product Portfolio
  6. 6.1.5 Avexis/Novartis (Zolgensma) Recent Developments
  7. 6.2 BioMarin (Roctavian)
  8. 6.2.1 BioMarin (Roctavian) Company Information
  9. 6.2.2 BioMarin (Roctavian) Business Overview
  10. 6.2.3 BioMarin (Roctavian) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 BioMarin (Roctavian) AAV Gene Therapy Injection Product Portfolio
  12. 6.2.5 BioMarin (Roctavian) Recent Developments
  13. 6.3 CSL/uniQure (Hemgenix&Glybera)
  14. 6.3.1 CSL/uniQure (Hemgenix&Glybera) Company Information
  15. 6.3.2 CSL/uniQure (Hemgenix&Glybera) Business Overview
  16. 6.3.3 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 CSL/uniQure (Hemgenix&Glybera) AAV Gene Therapy Injection Product Portfolio
  18. 6.3.5 CSL/uniQure (Hemgenix&Glybera) Recent Developments
  19. 6.4 PTC Therapeutics (Upstaza)
  20. 6.4.1 PTC Therapeutics (Upstaza) Company Information
  21. 6.4.2 PTC Therapeutics (Upstaza) Business Overview
  22. 6.4.3 PTC Therapeutics (Upstaza) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 PTC Therapeutics (Upstaza) AAV Gene Therapy Injection Product Portfolio
  24. 6.4.5 PTC Therapeutics (Upstaza) Recent Developments
  25. 6.5 Sarepta Therapeutics (Elevidys)
  26. 6.5.1 Sarepta Therapeutics (Elevidys) Company Information
  27. 6.5.2 Sarepta Therapeutics (Elevidys) Business Overview
  28. 6.5.3 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Sarepta Therapeutics (Elevidys) AAV Gene Therapy Injection Product Portfolio
  30. 6.5.5 Sarepta Therapeutics (Elevidys) Recent Developments
  31. 6.6 Spark/Roche (Luxturna)
  32. 6.6.1 Spark/Roche (Luxturna) Company Information
  33. 6.6.2 Spark/Roche (Luxturna) Business Overview
  34. 6.6.3 Spark/Roche (Luxturna) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Spark/Roche (Luxturna) AAV Gene Therapy Injection Product Portfolio
  36. 6.6.5 Spark/Roche (Luxturna) Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Pfizer AAV Gene Therapy Injection Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Suzhou NoJieBeig (Pipeline)
  44. 6.8.1 Suzhou NoJieBeig (Pipeline) Company Information
  45. 6.8.2 Suzhou NoJieBeig (Pipeline) Business Overview
  46. 6.8.3 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Suzhou NoJieBeig (Pipeline) AAV Gene Therapy Injection Product Portfolio
  48. 6.8.5 Suzhou NoJieBeig (Pipeline) Recent Developments
  49. 6.9 Belief BioMed (Pipeline)
  50. 6.9.1 Belief BioMed (Pipeline) Company Information
  51. 6.9.2 Belief BioMed (Pipeline) Business Overview
  52. 6.9.3 Belief BioMed (Pipeline) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Belief BioMed (Pipeline) AAV Gene Therapy Injection Product Portfolio
  54. 6.9.5 Belief BioMed (Pipeline) Recent Developments
  55. 6.10 Beijing Innovikang (Pipeline)
  56. 6.10.1 Beijing Innovikang (Pipeline) Company Information
  57. 6.10.2 Beijing Innovikang (Pipeline) Business Overview
  58. 6.10.3 Beijing Innovikang (Pipeline) AAV Gene Therapy Injection Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Beijing Innovikang (Pipeline) AAV Gene Therapy Injection Product Portfolio
  60. 6.10.5 Beijing Innovikang (Pipeline) Recent Developments
7 North America
  1. 7.1 North America AAV Gene Therapy Injection Market Size (2021-2032)
  2. 7.2 North America AAV Gene Therapy Injection Market Size by Type
  3. 7.2.1 North America AAV Gene Therapy Injection Market Size by Type (2021-2026)
  4. 7.2.2 North America AAV Gene Therapy Injection Market Size by Type (2027-2032)
  5. 7.2.3 North America AAV Gene Therapy Injection Market Share by Type (2021-2032)
  6. 7.3 North America AAV Gene Therapy Injection Market Size by Application
  7. 7.3.1 North America AAV Gene Therapy Injection Market Size by Application (2021-2026)
  8. 7.3.2 North America AAV Gene Therapy Injection Market Size by Application (2027-2032)
  9. 7.3.3 North America AAV Gene Therapy Injection Market Share by Application (2021-2032)
  10. 7.4 North America AAV Gene Therapy Injection Market Size by Country
  11. 7.4.1 North America AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America AAV Gene Therapy Injection Market Size by Country (2021-2026)
  13. 7.4.3 North America AAV Gene Therapy Injection Market Size by Country (2027-2032)
  14. 7.4.4 North America AAV Gene Therapy Injection Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe AAV Gene Therapy Injection Market Size (2021-2032)
  2. 8.2 Europe AAV Gene Therapy Injection Market Size by Type
  3. 8.2.1 Europe AAV Gene Therapy Injection Market Size by Type (2021-2026)
  4. 8.2.2 Europe AAV Gene Therapy Injection Market Size by Type (2027-2032)
  5. 8.2.3 Europe AAV Gene Therapy Injection Market Share by Type (2021-2032)
  6. 8.3 Europe AAV Gene Therapy Injection Market Size by Application
  7. 8.3.1 Europe AAV Gene Therapy Injection Market Size by Application (2021-2026)
  8. 8.3.2 Europe AAV Gene Therapy Injection Market Size by Application (2027-2032)
  9. 8.3.3 Europe AAV Gene Therapy Injection Market Share by Application (2021-2032)
  10. 8.4 Europe AAV Gene Therapy Injection Market Size by Country
  11. 8.4.1 Europe AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe AAV Gene Therapy Injection Market Size by Country (2021-2026)
  13. 8.4.3 Europe AAV Gene Therapy Injection Market Size by Country (2027-2032)
  14. 8.4.4 Europe AAV Gene Therapy Injection Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China AAV Gene Therapy Injection Market Size (2021-2032)
  2. 9.2 China AAV Gene Therapy Injection Market Size by Type
  3. 9.2.1 China AAV Gene Therapy Injection Market Size by Type (2021-2026)
  4. 9.2.2 China AAV Gene Therapy Injection Market Size by Type (2027-2032)
  5. 9.2.3 China AAV Gene Therapy Injection Market Share by Type (2021-2032)
  6. 9.3 China AAV Gene Therapy Injection Market Size by Application
  7. 9.3.1 China AAV Gene Therapy Injection Market Size by Application (2021-2026)
  8. 9.3.2 China AAV Gene Therapy Injection Market Size by Application (2027-2032)
  9. 9.3.3 China AAV Gene Therapy Injection Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia AAV Gene Therapy Injection Market Size (2021-2032)
  2. 10.2 Asia AAV Gene Therapy Injection Market Size by Type
  3. 10.2.1 Asia AAV Gene Therapy Injection Market Size by Type (2021-2026)
  4. 10.2.2 Asia AAV Gene Therapy Injection Market Size by Type (2027-2032)
  5. 10.2.3 Asia AAV Gene Therapy Injection Market Share by Type (2021-2032)
  6. 10.3 Asia AAV Gene Therapy Injection Market Size by Application
  7. 10.3.1 Asia AAV Gene Therapy Injection Market Size by Application (2021-2026)
  8. 10.3.2 Asia AAV Gene Therapy Injection Market Size by Application (2027-2032)
  9. 10.3.3 Asia AAV Gene Therapy Injection Market Share by Application (2021-2032)
  10. 10.4 Asia AAV Gene Therapy Injection Market Size by Country
  11. 10.4.1 Asia AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia AAV Gene Therapy Injection Market Size by Country (2021-2026)
  13. 10.4.3 Asia AAV Gene Therapy Injection Market Size by Country (2027-2032)
  14. 10.4.4 Asia AAV Gene Therapy Injection Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa AAV Gene Therapy Injection Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Type
  3. 11.2.1 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa AAV Gene Therapy Injection Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Application
  7. 11.3.1 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa AAV Gene Therapy Injection Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Country
  11. 11.4.1 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa AAV Gene Therapy Injection Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa AAV Gene Therapy Injection Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst